NasdaqGM:NTLABiotechs
What Does a 58% Drop Mean for Intellia Therapeutics Stock in 2025?
Wondering if Intellia Therapeutics is undervalued, overpriced, or finally at a sweet spot? You are definitely not alone, as many investors are asking the same question with all the action in biotech stocks lately.
After a tough few weeks, Intellia’s share price has fallen by 16.6% in just the past 7 days and is down 58.5% over the last month. This may have some wondering if the market sees hidden risks or changing prospects.
Much of this recent volatility has been attributed...